Extending Prednisolone Treatment Does Not Reduce Relapses in Childhood Nephrotic Syndrome
Authors:
Open Access
- 1 January 2013
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 24 (1) , 149-159
Abstract
Prolonged prednisolone treatment for the initial episode of childhood nephrotic syndrome may reduce relapse rate, but whether this results from the increased duration of treatment or a higher cumulative dose remains unclear. We conducted a randomized, double-blind, placebo-controlled trial in 69 hospitals in The Netherlands. We randomly assigned 150 children (9 months to 17 years) presenting with nephrotic syndrome to either 3 months of prednisolone followed by 3 months of placebo (n=74) or 6 months of prednisolone (n=76), and median follow-up was 47 months. Both groups received equal cumulative doses of prednisolone (approximately 3360 mg/m2). Among the 126 children who started trial medication, relapses occurred in 48 (77%) of 62 patients who received 3 months of prednisolone and 51 (80%) of 64 patients who received 6 months of prednisolone. Frequent relapses, according to international criteria, occurred with similar frequency between groups as well (45% versus 50%). In addition, there were no statistically significant differences between groups with respect to the eventual initiation of prednisolone maintenance and/or other immunosuppressive therapy (50% versus 59%), steroid dependence, or adverse effects. In conclusion, in this trial, extending initial prednisolone treatment from 3 to 6 months without increasing cumulative dose did not benefit clinical outcome in children with nephrotic syndrome. Previous findings indicating that prolonged treatment regimens reduce relapses most likely resulted from increased cumulative dose rather than the treatment duration.Keywords
This publication has 32 references indexed in Scilit:
- Nephrotic syndrome in The Netherlands: a population-based cohort study and a review of the literaturePediatric Nephrology, 2011
- Early age at debut is a predictor of steroid-dependent and frequent relapsing nephrotic syndromePediatric Nephrology, 2010
- A paediatric bone index derived by automated radiogrammetryOsteoporosis International, 2009
- Management patterns of childhood-onset nephrotic syndromePediatric Nephrology, 2009
- Risk factors for steroid dependency in children with idiopathic nephrotic syndromePediatric Nephrology, 2001
- Body growth of children with steroid-resistant nephrotic syndromePediatric Nephrology, 1999
- Prolonged versus standard prednisolone therapy for initial episode of nephrotic syndromePediatric Nephrology, 1999
- Short versus long initial prednisone treatment in steroid‐sensitive nephrotic syndrome in childrenActa Paediatrica, 1995
- Early identification of frequent relapsers among children with minimal change nephrotic syndromeThe Journal of Pediatrics, 1982
- The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisoneThe Journal of Pediatrics, 1981